Mark Alderson
28Patents
14h-index
33Co-inventors
77Inventor score
Filing activity: Nov 12, 1993 → Dec 21, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6355779B1 | Cytokine designated 4-1BB ligand antibodies and human receptor that binds thereto | Chemistry; Metallurgy | 104 | Expired |
| US5674704A | Cytokine designated 4-IBB ligand | Chemistry; Metallurgy | 65 | Expired |
| US6555653B2 | Compounds for diagnosis of tuberculosis and methods for their use | Chemistry; Metallurgy | 52 | Expired |
| US7261897B2 | Fusion proteins of mycobacterium tuberculosis | Chemistry; Metallurgy | 40 | Expired |
| US5801227A | Antibodies to CD40 | Chemistry; Metallurgy | 40 | Expired |
| US6627198B2 | Fusion proteins of Mycobacterium tuberculosis antigens and their uses | Chemistry; Metallurgy | 31 | Expired |
| US6613881B1 | Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use | Chemistry; Metallurgy | 30 | Expired |
| US6544522B1 | Fusion proteins of mycobacterium tuberculosis antigens and their uses | Chemistry; Metallurgy | 28 | Expired |
| US7138500B1 | Antibodies to human 4-1BB | Chemistry; Metallurgy | 23 | Expired |
| US7186412B1 | Fusion proteins of Mycobacterium tuberculosis | Chemistry; Metallurgy | 20 | Expired |
| US7083796B2 | Fusion proteins of mycobacterium tuberculosis | Chemistry; Metallurgy | 18 | Expired |
| US7064195B2 | Fusion proteins of mycobacterium tuberculosis antigens and their uses | Chemistry; Metallurgy | 16 | Expired |
| US7335369B2 | Fusion proteins of mycobacterium tuberculosis antigens and their uses | Chemistry; Metallurgy | 15 | Active |
| US6977069B2 | Fusion proteins of Mycobacterium tuberculosis antigens and their uses | Chemistry; Metallurgy | 15 | Expired |
| US5830469A | Fas antagonists and uses thereof | Chemistry; Metallurgy | 14 | Expired |
| US5620889A | Human anti-Fas IgG1 monoclonal antibodies | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5726286A | Isolated epstein-barr virus BZLF2 proteins that bind MHC class II beta chains | Chemistry; Metallurgy | 6 | Expired |
| US8143386B2 | Fusion proteins of mycobacterium tuberculosis antigens and their uses | Chemistry; Metallurgy | 5 | Active |
| US5474769A | Treatment of microbial infection by monocyte stimulation with interleukin-7 | Human Necessities | 4 | Expired |
| US8541007B2 | Vaccines against chlamydial infection | Human Necessities | 3 | Active |
| US5716623A | Isolated Herpesvirus saimiri proteins that bind MHC Class II molecules | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6015559A | Fas antagonists | Chemistry; Metallurgy | 3 | Expired |
| US8071747B2 | Fusion proteins of mycobacterium tuberculosis | Chemistry; Metallurgy | 3 | Active |
| US5681557A | Use of interleukin-7 to induce monocytes/macrophages cytotoxic activity | Human Necessities | 1 | Expired |
| US9827299B2 | Selectively disrupted whole-cell vaccine | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.